clinical trials in DMD - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Is DLL3 becoming the most strategic biomarker target in neuroendocrine oncology?

realme Buds T310 in Agile White: top true wireless earbuds under ₹2,000

realme Buds T310 review: Are these the best budget ANC earbuds under ₹2,000?

Why support-platform strategy may become a differentiator in schizophrenia treatment markets

Representative image of gold bars and tanker traffic in the Strait of Hormuz, illustrating why gold prices climbed to a one-month high even as the waterway was declared completely open.

What gold’s latest rally says about geopolitical hedging after the Strait of Hormuz reopening

Pfizer Inc.'s CIFFREO study on gene therapy for Duchenne muscular dystrophy did not meet its primary motor function improvement endpoint.

Read More

Pharma Industry News

Pfizer’s CIFFREO Phase 3 study in DMD fails to meet primary endpoint

Pfizer Inc. (NYSE: PFE), a global leader in pharmaceuticals, faced a setback as their CIFFREO Phase 3 study…

byPallavi Madhiraju

June 14, 2024

web analytics